Suresh Ramalingam, MD, FACP, FASCO; Winship Cancer Institute of Emory University; 5Live; #IASLC21
9:26
Non Small Cell Lung Cancer
Suresh Ramalingam, MD, FACP, FASCO; Winship Cancer Institute of Emory University; 5Live; #IASLC21
Non Small Cell Lung Cancer Similar Videos
Similar Videos
-
Update on treatment of unresectable stage III NSCLC_Jeff Bradley, MD, FACR, FASTRO; #DDHO2021
1:18
-
Q&A and Panel Discussion
6:40
-
Suresh Ramalingam, MD, FASCO; Winship Cancer Institute Emory University 5Live #ASCO20
5:27
Key insights on Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
